Clinical Trial Update: Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the combination of letrozole and trastuzumab in metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Metastatic Breast Cancer | Phase 4 | Status: TERMINATED